The Ministry of Food and Drug Safety announced on the 17th that it has organized and is operating a ‘Clinical Trial Consultative Body’ with the industry to hold an ear out to the domestic clinical trial industry’s opinion and facilitate the smooth operation of the systems that are being newly introduced.

The consultative body will consist of 14 members, experts in the bio-industry, including pharmaceuticals, vaccines, and cell therapies recommended by associations (Korea Pharmaceutical and Bio-Pharma Manufacturers Association, Korean Research-based Pharmaceutical Industry Association, Korea Biomedicine Industry Association), and the 1st meeting of the body was held on the 13th (Thurs) at the KRPIA